ANTIDIABETIC AGENTS > K-GLIM-Trio Tablets
For the use of a Registered Medical Practitioner, a Hospital or a Laboratory only.
COMPOSITION
K-GLIM-Trio 1mg Tablets
Each Uncoated Bilayared Tablet Contains:
Metformin Hydrochloride IP (in sustained release form) 500 mg
Voglibose IP 0.2 mg
Glimepiride IP 1 mg
 
K-GLIM-Trio 2mg Tablets
Each Uncoated Bilayared Tablet Contains:
Metformin Hydrochloride IP (in sustained release form) 500 mg
Voglibose IP 0.2 mg
Glimepiride IP 2 mg
 
INDICATIONS
K-GLIM-Trio Tablets are indicated for the treatment of type 2 diabetes when diet, exercise and dual combination therapy do not result in adequate glycemic control.

DOSAGE AND ADMINISTRATION
Oral: Adults: Initiate dose with one tablet once daily, and gradually titrate to twice daily after assessing the therapeutic response. Or, as prescribed by the physician. Maximum recommended daily doses of individual ingredients: Metformin: 2 g in divided dosage. Voglibose: 1.8 mg in divided dosage. Glimepiride: 8 mg in 1 or 2 divided dosage.
HOW SUPPLIED
10 Tablets per strip.